NEW YORK, Feb. 05, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Imprivata, Inc. (“Imprivata” or the “Company”) (NYSE:IMPR) in the United States District Court of Massachusetts on behalf of a class consisting of all persons or entities who purchased Imprivata securities between July 30, 2015 and November 2, 2015, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or omitted material information concerning demand for the Company’s IT security offerings and its sales trends, which inflated the price of Imprivata stock. The Complaint further alleges that certain Company executives and insiders took advantage of the inflation by selling more than $72 million worth of personally-held Imprivata stock during this time period.
If you wish to serve as lead plaintiff, you must move the Court no later than April 4, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 



